Kadadasu Ramyasri, Atchuta Abhinav, Palaparthy Rajababu, Reddy S Harinath, Sisinty Vidyasagar, Beeravolu Mounika
Department of Periodontics, Kamineni Institute of Dental Sciences, Nalgonda, Telangana, India.
J Oral Maxillofac Pathol. 2020 Jan-Apr;24(1):26-32. doi: 10.4103/jomfp.JOMFP_253_19. Epub 2020 May 8.
To evaluate the clinical and microbiological effects of local drug delivery of moxifloxacin and ibuprofen gel as an adjunct to conventional periodontal therapy in chronic periodontitis patients.
Twenty patients with moderate-to-severe chronic generalized periodontitis with probing pocket depth (PPD) of ≥5 mm and <8 mm were randomly assigned to one of the following two treatment modalities: scaling and root planing (SRP) group and moxifloxacin and ibuprofen combination gel as an adjunct to SRP group. Clinical parameters include plaque index (PI), gingival index (GI), probing depths and clinical attachment level (CAL) that were recorded at baseline and 1 and 3 months after the treatment, and microbiologic assessment was done using dark-field microscopy.
A statistically significant difference in mean PI and GI scores and reduction in PPD and gain in CAL were observed at different study intervals with greater difference in the test group. On microbiological examination, the percentage of cocci increased, while a statistically significant decrease in the mean percentage of bacilli and spirochetes was observed in both groups at given intervals. In-vitro dissolution showed controlled release of both the drugs.
Among the two treatment modalities, treatment with moxifloxacin and ibuprofen local delivery as an adjunct to SRP gave superior results in clinical and microbiological parameters compared to SRP group.
评估莫西沙星和布洛芬凝胶局部给药作为慢性牙周炎患者常规牙周治疗辅助手段的临床和微生物学效果。
20例中度至重度慢性广泛性牙周炎患者,探诊深度(PPD)≥5mm且<8mm,随机分为以下两种治疗方式之一:龈下刮治和根面平整(SRP)组以及莫西沙星和布洛芬联合凝胶作为SRP辅助治疗组。临床参数包括菌斑指数(PI)、牙龈指数(GI)、探诊深度和临床附着水平(CAL),在基线以及治疗后1个月和3个月进行记录,并使用暗视野显微镜进行微生物学评估。
在不同研究时间段,观察到平均PI和GI评分、PPD降低以及CAL增加方面存在统计学显著差异,试验组差异更大。微生物学检查显示,球菌百分比增加,而在给定时间段两组中杆菌和螺旋体的平均百分比均出现统计学显著下降。体外溶出显示两种药物均为控释。
在两种治疗方式中,与SRP组相比,莫西沙星和布洛芬局部给药作为SRP辅助治疗在临床和微生物学参数方面取得了更好的效果。